Pooled cellular immunogenicity for recombinant herpes zoster vaccine compared with control arm at end of follow-up period.

Pooled cellular immunogenicity for recombinant herpes zoster vaccine compared with control arm at end of follow-up period.

<p>Long-term data on cellular immunogenicity with the vaccine and control arms.</p> <p>(TIF)</p>

Saved in:
Bibliographic Details
Main Author: Fawziah Marra (269802) (author)
Other Authors: Michael Yip (20324056) (author), Jacquelyn J. Cragg (9906848) (author), Nirma Khatri Vadlamudi (9443783) (author)
Published: 2024
Subjects:
Medicine
Biotechnology
Evolutionary Biology
Immunology
Cancer
Science Policy
Infectious Diseases
systemic adverse events
serious adverse events
randomized clinical trials
preexisting autoimmune diseases
pooled using random
moderate heterogeneity across
herpes zoster infection
herpes zoster across
recombinant zoster vaccine
evaluating rzv compared
herpes zoster
xlink ">
systematic search
systematic review
rzv reduces
rzv reduced
routinely offered
past malignancy
october 2023
level characteristics
last dose
january 1984
immunocompromised adults
immune responses
data sources
cochrane central
advisory committee
44 ),
07 ).
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items